ArticlebioRxiv : the preprint server for biology2026
Membrane-associated periodic skeleton regulates major forms of endocytosis in neurons through a signaling-driven positive feedback loop.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Endocytosis is an evolutionarily conserved process that enables neurons to internalize signaling receptors and membrane proteins, maintaining cellular homeostasis and supporting rapid responses to extracellular cues. The neuronal membrane-associated periodic skeleton (MPS), a lattice-like cytoskeletal structure composed of actin and spectrin, has been shown to restrict clathrin-mediated endocytosis (CME) at the axon initial segment (AIS) of neurons, by gating clathrin-coated pit (CCP) formation through membrane-localized "clearing" structures that are devoid of MPS. However, the extent to which the MPS regulates diverse forms of endocytosis across neuronal compartments, and how it is dynamically remodeled to permit trafficking on demand, remain unknown. While CME is relatively well characterized in neurons, the subcellular localization and physiological relevance of caveolin-mediated endocytosis, flotillin-mediated endocytosis, and fast endophilin-mediated endocytosis (FEME) have remained largely unclear. Here, we show that all four major endocytic pathways-CME, caveolin-, flotillin-, and FEME- are spatially gated by the MPS and occur specifically within MPS-free "clearing" zones distributed across both axonal and somatodendritic compartments of mature neurons. These results, for the first time, map the spatial landscape of these lesser-understood pathways in neurons and reveal a unifying principle of cytoskeletal gating across endocytic mechanisms. Disruption of the MPS markedly enhances both basal and ligand-induced endocytosis across all four pathways, establishing its broad inhibitory role in pit initiation. We further discover that endocytosis can, in turn, remodel the MPS through a novel signalling-driven feedback loop: ligand-triggered endocytosis activates ERK signaling, which promotes calpain- and caspase-mediated spectrin cleavage. This targeted cytoskeletal degradation facilitates further rounds of endocytosis, forming a self-reinforcing circuit that couples membrane trafficking with cortical architecture remodeling. Finally, we show that the MPS limits amyloid precursor protein (APP) endocytosis and thereby suppresses amyloid-β 1-42 (Aβ42) production and neuronal apoptosis, implicating MPS integrity in the regulation of neurodegenerative processes such as Alzheimer's disease. Together, our findings establish the MPS as a dynamic, signal-responsive modulator of endocytosis and neuronal health. This work uncovers a general spatial gating mechanism that applies to diverse endocytic pathways, introduces a cytoskeleton-centered feedback loop for signal-dependent remodeling, and expands the functional significance of the MPS from passive structural support to active regulation of neuronal homeostasis and disease susceptibility.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.